Table 3 Pathways over-represented in the first-order 812 gene network

Pathways in cancer

6.53E−47

1.42E−44

ErbB signaling pathway

1.35E−26

1.47E−24

Chronic myeloid leukemia

3.38E−26

2.45E−24

HTLV-I infection

5.30E−26

2.78E−24

WNT signaling pathway

6.41E−26

2.78E−24

Focal adhesion

4.23E−23

1.53E−21

Pancreatic cancer

8.10E−22

2.51E−20

Neurotrophin signaling pathway

1.39E−21

3.78E−20

Prostate cancer

1.27E−20

3.07E−19

Colorectal cancer

1.21E−19

2.63E−18

Osteoclast differentiation

3.84E−19

7.58E−18

Acute myeloid leukemia

4.98E−19

9.01E−18

Hepatitis C

8.76E−19

1.46E−17

T cell receptor signaling pathway

1.02E−18

1.58E−17

Melanogenesis

2.02E−18

2.92E−17

Regulation of actin cytoskeleton

2.39E−18

3.24E−17

Chagas disease (American trypanosomiasis)

4.82E−18

6.15E−17

MAPK signaling pathway

1.51E−17

1.82E−16

B cell receptor signaling pathway

7.04E−17

8.04E−16

Gap junction

1.99E−16

2.16E−15

Renal cell carcinoma

2.51E−16

2.60E−15

Epstein-Barr virus infection

9.93E−16

9.79E−15

Cell cycle

1.37E−15

1.30E−14

Axon guidance

2.90E−15

2.62E−14

Toll-like receptor signaling pathway

3.02E−15

2.62E−14

Glioma

5.85E−15

4.88E−14

Herpes simplex infection

7.95E−15

6.39E−14